Department of Breast Surgery, Hiroshima City Hospital, and Department of Pathology, Graduate School of Biomedical Sciences, Hiroshima University, 7-33 Moto-machi, Naka-ku, Hiroshima 730-8518, Japan.
Breast. 2011 Oct;20(5):431-6. doi: 10.1016/j.breast.2011.04.007. Epub 2011 Jun 8.
To examine the radiofrequency ablation (RFA) reliability in early breast cancer, we performed RFA followed by delayed surgical resection on 41 patients with invasive or non-invasive breast carcinoma less than 2 cm. MRI scans were obtained before ablation and resection. Excised specimens were examined pathologically by haematoxylin-eosin and nicotinamide adenine dinucleotide-diaphorase staining. 40 patients completed 1 RFA session, which was sufficient to achieve complete tumour cell death. Overall complete ablation rate was 87.8% (36/41). There were no treatment-related complications other than that of a superficial burn in 1 case. After RFA, the tumour was no longer enhanced on MRI in 25/26 (96.2%) cases. Residual cancer, which was suspected on MRI in 1 case, was confirmed pathologically. MRI could be an applicable modality to evaluate therapeutic effect. RFA could be an alternate local treatment option to breast-conserving surgery for early breast cancer.
为了研究射频消融(RFA)在早期乳腺癌中的可靠性,我们对 41 例浸润性或非浸润性小于 2cm 的乳腺癌患者进行了 RFA 后延迟手术切除。消融前和切除前均进行了 MRI 扫描。切除标本用苏木精-伊红和烟酰胺腺嘌呤二核苷酸-黄递酶染色进行病理检查。40 例患者完成了 1 次 RFA 治疗,足以达到完全肿瘤细胞死亡。总体完全消融率为 87.8%(36/41)。除 1 例浅表烧伤外,无其他治疗相关并发症。RFA 后,26 例中的 25 例(96.2%)肿瘤在 MRI 上不再增强。1 例 MRI 上怀疑残留癌症的病例,经病理证实。MRI 可以作为评估治疗效果的一种适用方式。RFA 可能是早期乳腺癌保乳手术的一种替代局部治疗选择。